GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Predictive Technology Group Inc (OTCPK:PRED) » Definitions » EV-to-EBIT

Predictive Technology Group (Predictive Technology Group) EV-to-EBIT : -0.00 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Predictive Technology Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Predictive Technology Group's Enterprise Value is $0.09 Mil. Predictive Technology Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 was $-61.88 Mil. Therefore, Predictive Technology Group's EV-to-EBIT for today is -0.00.

The historical rank and industry rank for Predictive Technology Group's EV-to-EBIT or its related term are showing as below:

PRED's EV-to-EBIT is not ranked *
in the Biotechnology industry.
Industry Median: 10.09
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Predictive Technology Group's Enterprise Value for the quarter that ended in Mar. 2021 was $60.76 Mil. Predictive Technology Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 was $-61.88 Mil. Predictive Technology Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2021 was -101.85%.


Predictive Technology Group EV-to-EBIT Historical Data

The historical data trend for Predictive Technology Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Technology Group EV-to-EBIT Chart

Predictive Technology Group Annual Data
Trend Aug06 Aug07 Jun16 Jun17 Jun18 Jun19 Jun20
EV-to-EBIT
Get a 7-Day Free Trial -64.37 -48.64 -17.74 -60.68 -1.39

Predictive Technology Group Quarterly Data
Nov07 Feb08 May08 Jun16 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.88 -1.39 -0.59 -0.42 -0.98

Competitive Comparison of Predictive Technology Group's EV-to-EBIT

For the Biotechnology subindustry, Predictive Technology Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Technology Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Predictive Technology Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Predictive Technology Group's EV-to-EBIT falls into.



Predictive Technology Group EV-to-EBIT Calculation

Predictive Technology Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.090/-61.884
=-0.00

Predictive Technology Group's current Enterprise Value is $0.09 Mil.
Predictive Technology Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-61.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predictive Technology Group  (OTCPK:PRED) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Predictive Technology Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2021 ) =EBIT / Enterprise Value (Q: Mar. 2021 )
=-61.884/60.76052
=-101.85 %

Predictive Technology Group's Enterprise Value for the quarter that ended in Mar. 2021 was $60.76 Mil.
Predictive Technology Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-61.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predictive Technology Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Predictive Technology Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Technology Group (Predictive Technology Group) Business Description

Traded in Other Exchanges
N/A
Address
2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.

Predictive Technology Group (Predictive Technology Group) Headlines

From GuruFocus

Predictive Technology Group Provides Stock Trading Platform Update

By Marketwired Marketwired 11-11-2019